Sponsored Links
| FDA Approves Lamictal®XR™ (Lamotrigine) For Conversion To Monotherapy For Treatment Of Partial Seizures In Appropriate Patients |
 |
 |
 |
| Medical News - Epilepsy | |||
|
GlaxoSmithKline (GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Lamictal® XR™ (lamotrigine) Extended-Release Tablets for conversion to monotherapy in patients 13 years and older with partial seizures taking one anti-epileptic drug... Read more: Epilepsy News From Medical News Today
|